Regentis Biomaterials Ltd. RGNT
Set alert
1.37 USD 0.00 0.00%
At close · Nov 2
1.38 +0.01 +0.73%
After hours · Nov 2, 4:00 PM ET
1.37 Day range 1.43
1.23 52-week range 15.50
- YTD
- -79.67%
- 1 year
- -81.73%
- Open
- 1.36
- Prev close
- 1.37
- Mkt cap
- 9.62M
- Vol
- 15.30K
- Avg vol
- 49.95K
- EPS
- -2.46
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.37
- High
- 1.43
1Y chart
Signals (27)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 2026 | 12 hours ago |
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 15, 2026 | 4 months ago |
| RSI: Overbought | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 9, 2026 | 4 months ago |
| RSI: Oversold | Jun 5, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| RSI: Oversold | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| RSI: Oversold | May 4, 2026 | 6 months ago |
| RSI: Oversold | Mar 24, 2026 | 7 months ago |
| RSI: Oversold | Mar 20, 2026 | 7 months ago |
| RSI: Oversold | Mar 13, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 6, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| RSI: Oversold | Mar 2, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 27, 2026 | 8 months ago |
| RSI: Oversold | Feb 5, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 27, 2026 | 9 months ago |
Financials — quick view
RGNT Revenue — quarterly 16.78M
RGNT Net income — quarterly -2.24M
RGNT EPS — quarterly -0.55
News
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal
- Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City
- 12 Health Care Stocks Moving In Monday's Intraday Session
- IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Ehud Geller, CEO of Regentis Biomaterials Ltd.
- Regentis Biomaterials H1 EPS $(0.44) Up From $(1.17) YoY
- Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Regentis Gets Japan Patent Office Notice of Allowance For Organic Solvent‑Free Protein‑Polymer Conjugate Compositions, Covering GelrinC Manufacturing Process And Ready‑to‑Use Liquid Formulation for Articular Cartilage Repair
Your note
Sign in to keep a note on RGNT — it syncs with the Stock Master app.